ARIKAYCE

Drug Insmed, Inc.
Total Payments
$15,076
Transactions
21
Doctors
4
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2019 $15,076 21 4

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,875 7 78.8%
Travel and Lodging $2,823 10 18.7%
Food and Beverage $378.44 4 2.5%

Top Doctors Receiving Payments for ARIKAYCE

Doctor Specialty Location Total Records
, MD Pulmonary Disease New York, NY $8,803 14
, MD Internal Medicine Anderson, SC $2,614 2
, M.D Pulmonary Disease Norfolk, VA $2,015 2
, MD Critical Care Medicine Jamaica, NY $1,644 3

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $15,076
  • Total Doctors 4
  • Transactions 21

About ARIKAYCE

ARIKAYCE is a drug associated with $15,076 in payments to 4 healthcare providers, recorded across 21 transactions in the CMS Open Payments database. The primary manufacturer is Insmed, Inc..

Payment data is available from 2019 to 2019. In 2019, $15,076 was paid across 21 transactions to 4 doctors.

The most common payment nature for ARIKAYCE is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,875, 78.8% of total).